Novel Antimalarial Drug Candidates Generated In Silico by Analysis of Public HTS Data
Poster Sep 24, 2012
Robert Fraczkiewicz, Michael S. Lawless, Robert D. Clark, and Walter S. Woltosz
The World Health Organization has estimated that over 200 million people suffered from malaria in 2010 and that over 600,000 people died from it that year. Growing problems with resistance to existing anti-malarial drugs makes identification of new drugs a high priority. We applied a series of state-of-the-art In Silico tools to publicly available activity data from screens carried out on intact Plasmodium falciparum parasites to yield a handful of candidate molecules predicted to combine potency with good absorption, distribution, metabolism, excretion and toxicity (ADMET) properties. Here we describe the overall process used to design these molecules and report encouraging results for their activity against the parasite in culture. We also show that the ADMET properties predicted for them generally compare well to the experimentally determined values.
CiPA Phase 2 Study: validation of an automated microelectrode array (MEA) assay of hiPSC-derived cardiomyocyte electrophysiology for cardiac safety evaluationPoster
These results support the use of hSC-CM and MEA technology for preclinical assessment of proarrhythmic risk within the proposed CiPA paradigm, and, more generally, demonstrate that automation of the CM-MEA assay can achieve high reliability and throughput for cardiac risk assessment in vitro.READ MORE
A luminescent solar concentrator-based photomicroreactor for energy efficient continuous-flow photocatalysisPoster
The Luminescent Solar ConcentratorPhotomicroreactor
(LSC-PM) is an innovative device
for solar-powered continuous-flow photochemistry.